News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Genentech, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Job Trends
With Bristol-Myers Squibb, Genentech and Merck & Co. Expanding in the Bay Area, Some Wonder if the Real Estate Boom is Too Much
November 14, 2016
·
2 min read
Job Trends
Genentech Snaps Up Four Buildings it Had Been Leasing Since 2006
November 10, 2016
·
2 min read
With New Owners, Ambrx, Inc. Aims To Challenge Genentech
November 3, 2016
·
1 min read
Business
Meet the Cancer Scientist Leading Genentech’s First Podcast
October 25, 2016
·
2 min read
FDA
Genentech’s Tecentriq Wins Second Approval of the Year, This Time for Lung Cancer
October 19, 2016
·
11 min read
Drug Development
Genentech’s Lung Cancer Drug Alecensa Gets 2nd FDA Breakthrough Status
October 4, 2016
·
2 min read
Business
Next in a String of Deals, Korea’s Hanmi Pharma Inks $910M Deal with Genentech
September 29, 2016
·
2 min read
Business
Genentech Gambles $310 Million+ on German Biotech BioNTech’s mRNA Cancer Vaccine Tech
September 21, 2016
·
2 min read
Drug Development
Cancer Drug Developed by Eliza Hall Institute, AbbVie and Genentech “Melts Away Cancer”
September 7, 2016
·
2 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Genentech Announces Positive Phase II Results for Petrelintide, an Amylin Analog Developed for People Living With Overweight and Obesity
March 5, 2026
·
6 min read
Press Releases
Genentech’s Fenebrutinib Confirms Its Potential as First and Only BTK Inhibitor for Relapsing and Primary Progressive MS in Third Positive Phase III Study (FENhance 1)
March 2, 2026
·
14 min read
Press Releases
Recursion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
February 25, 2026
·
22 min read
Press Releases
Genprex Strengthens Intellectual Property Portfolio with Japanese and EU Patents for Reqorsa® Gene Therapy in Combination with Immunotherapies to Treat Cancer
February 23, 2026
·
7 min read
Press Releases
FDA Approves Genentech’s Venclexta® Plus Acalabrutinib Combination Regimen for Previously Untreated Chronic Lymphocytic Leukemia
February 20, 2026
·
17 min read
Press Releases
FDA Accepts New Drug Application for Genentech’s Giredestrant in ESR1-Mutated, ER-Positive Advanced Breast Cancer
February 20, 2026
·
8 min read
Press Releases
U.S. Food and Drug Administration (FDA) Approves Combination Treatment of VENCLEXTA® (venetoclax) and Acalabrutinib for Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL)
February 20, 2026
·
13 min read
Press Releases
FDA accepts New Drug Application for Roche’s giredestrant in ESR1-mutated, ER-positive advanced breast cancer
February 20, 2026
·
13 min read
Press Releases
Genentech Announces Positive Phase III Results for Gazyva in Primary Membranous Nephropathy, Marking a Significant Milestone in This Autoimmune Disease
February 16, 2026
·
12 min read
Press Releases
Genentech’s Fenebrutinib Is the First Investigational Medicine in Over a Decade That Reduces Disability Progression in Primary Progressive Multiple Sclerosis (PPMS)
February 9, 2026
·
17 min read
